- 专利标题: Polyalkylene oxide-modified single chain polypeptides
-
申请号: US10915069申请日: 2004-08-10
-
公开(公告)号: US07150872B2公开(公告)日: 2006-12-19
- 发明人: Marc Whitlow , Robert G. L. Shorr , David R. Filpula , Lihsyng Standford Lee
- 申请人: Marc Whitlow , Robert G. L. Shorr , David R. Filpula , Lihsyng Standford Lee
- 申请人地址: US NJ Piscataway
- 专利权人: Enzon, Inc.
- 当前专利权人: Enzon, Inc.
- 当前专利权人地址: US NJ Piscataway
- 代理机构: Lucas & Mercanti, LLP
- 主分类号: A61K39/40
- IPC分类号: A61K39/40 ; C07K16/00 ; C12Q1/68
摘要:
The present invention relates to the chemical modification of single chain polypeptides by means of covalent attachment of strands of poly(ethylene glycol) PEG and similar poly(alkylene oxides) to single chain polypeptide binding molecules that have the three dimensional folding and, thus, the binding ability and specificity, of the variable region of an antibody. Such preparations of modified single chain polypeptide binding molecules have reduced immugenicity and antigenicity as well as having a longer halflife in the bloodstream as compared to the parent polypeptide. These beneficial properties of the modified single chain polypeptide binding molecules make them very useful in a variety of therapeutic applications. The invention also relates to multivalent antigen-binding molecules capable of PEGylation. Compositions of, genetic constructions for, methods of use, and methods for producing PEGylated antigen-binding proteins are disclosed.
公开/授权文献
- US20050008650A1 Polyalkylene oxide-modified single chain polypeptides 公开/授权日:2005-01-13
信息查询